Winrevair (sotatercept)

pCPA File Number: 22911
Negotiation Status:
Active Negotiation
Indication(s):
Pulmonary Arterial Hypertension (WHO group 1)
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SR0828-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable